Study of Pembrolizumab in Metastatic HER2-negative Breast Cancer Patients With APOBEC3B Mutation

NCT03989089 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Malaya

Collaborators